Pharmacologic Inhibition of Poly(ADP-Ribose) Polymerase Is Neuroprotective Following Traumatic Brain Injury in Rats-Reference-Cited by-同舟云学术

Pharmacologic Inhibition of Poly(ADP-Ribose) Polymerase Is Neuroprotective Following Traumatic Brain Injury in Rats

Published:2001-04 Issue:4 Volume:18 Page:369-376
ISSN:0897-7151
Container-title:Journal of Neurotrauma
language:en
Short-container-title:Journal of Neurotrauma

Author:

LaPlaca Michelle C.¹,Zhang Jie²,Raghupathi Ramesh¹,Li Jia-He²,Smith Fraser³,Bareyre Florence M.¹,Snyder Solomon H.³,Graham David I.⁴,McIntosh Tracy K.¹

Affiliation:

1. Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania

2. Guilford Pharmaceuticals, Inc., Baltimore, Maryland

3. Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland

4. Department of Neuropathology, Southern General Hospital, Glasgow, Scotland

Publisher

Mary Ann Liebert Inc

Subject

Neurology (clinical)

Link

http://www.liebertpub.com/doi/pdf/10.1089/089771501750170912

Reference43 articles.

1. Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks.

2. Early Detection of DNA Strand Breaks in the Brain After Transient Focal Ischemia: Implications for the Role of DNA Damage in Apoptosis and Neuronal Cell Death

3. Apoptosis-Suppressor Genebcl-2Expression after Traumatic Brain Injury in Rats

4. Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: possible role in spatial memory deficits

5. Experimental Brain Injury Induces Regionally Distinct Apoptosis during the Acute and Delayed Post-Traumatic Period

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traumatic Brain Injury: A Comprehensive Review of Biomechanics and Molecular Pathophysiology;World Neurosurgery;2024-05

2. Nicotinamide Adenine Dinucleotide (NAD⁺)-Dependent Signaling in Neurological Disorders;Antioxidants & Redox Signaling;2023-12-01

3. Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain Injury;Neurotherapeutics;2023-10

4. Colloidal therapeutics in the management of traumatic brain injury: Portray of biomarkers and drug-targets, preclinical and clinical pieces of evidence and future prospects;Colloids and Surfaces B: Biointerfaces;2023-10

5. Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury;Neurobiology of Disease;2023-05